Evaluation of gastric antiprotease-antipepsin activity of carrageenan in humans.
D000328:Adult; D000687:Amylopectin / Q000494:pharmacology; D002351:Carrageenan / Q000032:analysis / Q000494:pharmacology*; D003911:Dextrans / Q000494:pharmacology; D004105:Diiodotyrosine / Q000031:analogs & derivatives / Q000494:pharmacology; D004151:Dipeptides / Q000494:pharmacology; D005745:Gastric Acidity Determination; D005750:Gastric Juice / Q000201:enzymology*; D005753:Gastric Mucosa / Q000187:drug effects; D006801:Humans; D066298:In Vitro Techniques; D007441:Intubation, Gastrointestinal; D008297:Male; D010434:Pepsin A / Q000037:antagonists & inhibitors*; D010649:Phenylalanine / Q000494:pharmacology; D011134:Polysaccharides / Q000494:pharmacology; D011480:Protease Inhibitors; D013431:Sulfates / Q000494:pharmacology
D003911:Dextrans; D004151:Dipeptides; D011134:Polysaccharides; D011480:Protease Inhibitors; D013431:Sulfates; D010649:Phenylalanine; D004105:Diiodotyrosine; D002351:Carrageenan; D000687:Amylopectin; D010434:Pepsin A